Qiagen NV (QGEN)
42.78
+0.45
(+1.06%)
USD |
NYSE |
Nov 22, 16:00
42.79
+0.01
(+0.02%)
After-Hours: 20:00
Qiagen Shareholders Equity (Quarterly): 3.530B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.530B |
June 30, 2024 | 3.405B |
March 31, 2024 | 3.600B |
December 31, 2023 | 3.808B |
September 30, 2023 | 3.694B |
June 30, 2023 | 3.624B |
March 31, 2023 | 3.561B |
December 31, 2022 | 3.467B |
September 30, 2022 | 3.328B |
June 30, 2022 | 3.282B |
March 31, 2022 | 3.240B |
December 31, 2021 | 3.097B |
September 30, 2021 | 3.014B |
June 30, 2021 | 2.978B |
March 31, 2021 | 2.850B |
December 31, 2020 | 2.798B |
September 30, 2020 | 2.711B |
June 30, 2020 | 2.621B |
March 31, 2020 | 2.492B |
December 31, 2019 | 2.537B |
September 30, 2019 | 2.467B |
June 30, 2019 | 2.632B |
March 31, 2019 | 2.606B |
December 31, 2018 | 2.635B |
September 30, 2018 | 2.527B |
Date | Value |
---|---|
June 30, 2018 | 2.524B |
March 31, 2018 | 2.581B |
December 31, 2017 | 2.541B |
September 30, 2017 | 2.567B |
June 30, 2017 | 2.505B |
March 31, 2017 | 2.430B |
December 31, 2016 | 2.607B |
September 30, 2016 | 2.666B |
June 30, 2016 | 2.621B |
March 31, 2016 | 2.625B |
December 31, 2015 | 2.566B |
September 30, 2015 | 2.518B |
June 30, 2015 | 2.534B |
March 31, 2015 | 2.471B |
December 31, 2014 | 2.650B |
September 30, 2014 | 2.705B |
June 30, 2014 | 2.746B |
March 31, 2014 | 2.724B |
December 31, 2013 | 2.714B |
September 30, 2013 | 2.666B |
June 30, 2013 | 2.586B |
March 31, 2013 | 2.681B |
December 31, 2012 | 2.715B |
September 30, 2012 | 2.702B |
June 30, 2012 | 2.632B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.492B
Minimum
Mar 2020
3.808B
Maximum
Dec 2023
3.182B
Average
3.261B
Median
Shareholders Equity (Quarterly) Benchmarks
LENZ Therapeutics Inc | 215.28M |
Oruka Therapeutics Inc | 342.37M |
Boston Scientific Corp | 20.71B |
Merus NV | 703.26M |
uniQure NV | 55.82M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.270B |
Total Liabilities (Quarterly) | 2.740B |
Debt to Equity Ratio | 0.5439 |
Current Ratio | 2.174 |
Net Debt Paydown Yield | -0.06% |